In conclusion, this study demonstrates that neoAg-mRNA-LNP vaccines elicit strong neoAg-specific CD8+ T cell responses, showing significant antitumor effects in gastric cancer, particularly when combined with anti-PD-1 therapy. Here, CD8A is linked to gastric cancer.